8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Moori M, Norouzian D, Yaghmaei P, Farahmand L

Bioeffects Seen

Authors not listed · 2024

Share:

Specific EMF exposure (1 Hz, 100 mT) reduced triple negative breast cancer cell invasion by reversing cadherin switching, but this controlled therapy differs completely from everyday EMF exposure.

Plain English Summary

Summary written for general audiences

Researchers exposed triple negative breast cancer cells to extremely low frequency electromagnetic fields (1 Hz, 100 mT) for 2 hours daily over 5 days. The EMF exposure significantly reduced cancer cell migration and invasion while increasing E-cadherin expression and decreasing N-cadherin expression, essentially reversing the molecular changes that make cancer cells more invasive. This suggests specific EMF parameters might help prevent breast cancer metastasis, the primary cause of cancer deaths.

Why This Matters

This study reveals something most people don't expect: under specific conditions, electromagnetic fields might actually suppress cancer spread rather than promote it. The science demonstrates that 1 Hz EMF exposure reversed cadherin switching, a key process that allows cancer cells to break away and metastasize. What makes this particularly noteworthy is the use of triple negative breast cancer cells, the most aggressive and treatment-resistant breast cancer type.

Before anyone considers this a therapeutic breakthrough, understand the context. The exposure used here (100 mT at 1 Hz for 2 hours daily) is vastly different from the random, continuous EMF exposure we get from cell phones, WiFi, and power lines, which operate at different frequencies and intensities. This was a controlled laboratory study on isolated cells, not humans. The reality is that we need to distinguish between intentional, targeted EMF therapy under medical supervision and the chronic, uncontrolled EMF exposure from everyday technology. This research suggests potential for future cancer treatment protocols, but it absolutely doesn't mean your wireless devices are protecting you from breast cancer. The frequency, intensity, duration, and biological context matter enormously.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 1 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 1 HzPower lines50/60 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2024). Moori M, Norouzian D, Yaghmaei P, Farahmand L.
Show BibTeX
@article{moori_m_norouzian_d_yaghmaei_p_farahmand_l_ce4158,
  author = {Unknown},
  title = {Moori M, Norouzian D, Yaghmaei P, Farahmand L},
  year = {2024},
  doi = {10.1080/15368378.2024.2381575},
  
}
DOI: 10.1080/15368378.2024.2381575PubMed: 39045872

Quick Questions About This Study

In laboratory tests, 1 Hz EMF at 100 mT reduced invasion and migration of aggressive breast cancer cells by affecting proteins that control cell adhesion. However, these are preliminary cell culture results, not human clinical trials. The specific parameters used don't match everyday EMF exposure from consumer devices.
Cadherin switching occurs when cancer cells decrease E-cadherin (which keeps cells stuck together) and increase N-cadherin (which helps cells move and invade). This molecular change enables cancer metastasis. The study found that specific EMF exposure reversed this process, increasing E-cadherin and decreasing N-cadherin in cancer cells.
The 100 milliTesla exposure used in this study is extremely high compared to typical environmental EMF. For context, that's roughly 1,000 times stronger than the magnetic field directly under high-voltage power lines. This was intentional therapeutic-level exposure in a laboratory setting, completely different from wireless device exposure.
Absolutely not. This study used highly specific parameters (1 Hz frequency, 100 mT intensity, 2 hours daily) on isolated cells to explore potential future therapy. The chronic, variable EMF exposure from phones, WiFi, and other devices operates at completely different frequencies and intensities with different biological effects.
Triple negative breast cancer is the most aggressive breast cancer type, lacking three common receptors that other treatments target. That the EMF exposure reduced invasion in these particularly resistant cells (MDA-MB-231 line) makes the findings more significant, though still preliminary and requiring extensive validation in human trials.